Aihua Huang

Oct 16, 2023 | bmccancer.biomedcentral.com | Qinchuan Wang |fei chen |Aihua Huang |Cong Chen |Yi Lu |Linbo Wang | +3 more

A total of 646 patients were included for the final analysis, with a median follow-up of 5.0 years (ranging from 0.4 to 18.0 years). The pretreatment characteristics, treatment strategies, as well as response and follow-up information of patients are summarized in Table 1. The median age of the cohort at diagnosis was 49 years old (ranging from 22 to 84). After NAC, 118 patients (18.2%) in the cohort experienced pCR, whereas 528 (81.7%) exhibited residual disease.